Pipette dripping water droplet with money symbol on it into test tube
Biotech

T-Therapeutics raises $133M series B with Big Pharma backers

Joined by pharma giants J&J, Lilly and Sanofi, the bispecific maker aims to bring its bispecifics to clinical proof of concept.
Michael Gibney Nov 5, 2026 4:00am
The cost of waiting What reaching clinical proof-of-concept sooner means for biotech cash burn

The cost of waiting: how early proof-of-concept shapes cash burn

Brought to you by Altasciences
Close up of amber eye

Cloudbreak posts ph. 3 eye disease win amid IPO storm

Nov 5, 2026 3:46am
Charles River booth at AACR 2026

Charles River teams up with Ipsen for toxicology studies

Nov 4, 2026 2:25pm
x

Fierce Biotech Layoff Tracker 2026: Ultragenyx & more

Nov 4, 2026 11:00am
Gavel
Favicon Fierce Pharma

Ex-Madrigal clinical head files Rezdiffra whistleblower suit

Nov 4, 2026 10:49am
More News

Minghui grants ASKA Japan rights to TED candidate in $440M deal

Nov 4, 2026 9:18am

Boehringer bags $7.4B Sino deal for 6 preclinical TCEs, ADCs

Nov 4, 2026 9:08am

nPhase rakes in $30M to expand AI-native clinical data platform

Nov 4, 2026 8:21am

AbbVie pens $1.4B deal for deprioritized IBD drug from Nxera

Nov 4, 2026 7:20am